Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2011
Non-invasive ventilation in motor neuron disease: an update of current UK practiceCatherine L O'Neill, Tim L Williams, Edwin T Peel, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 10, 2021
Effect of portable noninvasive ventilation on thoracoabdominal volumes in recovery from intermittent exercise in patients with COPDN Chynkiamis, N D Lane, D Megaritis, et al.
Psychological Medicine|October 9, 2015
No change in neuropsychological dysfunction or emotional processing during treatment of major depression with cognitive-behaviour therapy or schema therapyR J Porter, C Bourke, J D Carter, et al.
BMJ Open Respiratory Research|April 12, 2018
British Thoracic Society Quality Standards for acute non-invasive ventilation in adultsMichael Davies, Martin Allen, Andrew Bentley, et al.
Respiratory Medicine|May 16, 2013
Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort studyG A Anwar, M J McDonnell, S A Worthy, et al.
Thorax|January 16, 2016
Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPDC Echevarria, J Steer, K Heslop-Marshall, et al.
Thorax|February 26, 2017
The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPDC Echevarria, J Steer, K Heslop-Marshall, et al.
The European Respiratory Journal|January 22, 2021
The Noninvasive Ventilation Outcomes (NIVO) score: prediction of in-hospital mortality in exacerbations of COPD requiring assisted ventilationTom Hartley, Nicholas D Lane, John Steer, et al.
The Medical Journal of Australia|February 25, 2025
Mandatory research projects during medical specialist training in Australia and New Zealand: a survey of trainees' experiences and reportsPaulina Stehlik, Caitlyn Withers, Rachel C Bourke, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1997
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapyK A Ellem, M G O'Rourke, G R Johnson, et al.
Pageof 10